ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 6,990.00
-110.00 (-1.55%)
At close: Apr 30, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 519.8 billion as of April 30, 2026.
Market Cap
519.80B
Enterprise Value
496.44B
Revenue
111.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,990.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 519.80B, a decrease of -5.06%. That is a compound annual growth rate of -5.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 519.80B | -46.17% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.35T |
| Myung In Pharmaceutical LTD. | 827.82B |
| Samyang Biopharm | 598.59B |
| CellBion | 486.96B |
| HEM Pharma | 437.75B |
| DAE HWA Pharmaceutical | 263.10B |
| NOVAREX | 262.17B |
| GREEN CROSS WellBeing | 251.98B |